Two new studies now suggest that the strong magnets in MRI technology could be used to diagnose, treat and study inner ear disorders in the future, replacing more invasive and uncomfortable examinations.
News Updates: Research
The purpose of this clinical trial is to compare the use of vestibular exercises vs corticosteroid therapy in the recovery of patients with acute vestibular neuritis.
It is not uncommon to take a little time to find your land legs after being on a boat, with the sensation of being off balance or still rocking with the waves lasting for minutes, hours or, at most, a few days. However for some people this feeling lasts for years with debilitating consequences.
by Carolyn Y. Johnson / Globe Staff
A year ago, I wrote about promising work toward developing a drug that could help treat hearing loss. A group of researchers at Massachusetts Eye and Ear Infirmary had discovered that an experimental drug originally developed with the intent of treating Alzheimer’s disease could regenerate the delicate hair cells inside ears and restore rudimentary hearing when administered to deaf mice.
Research from Harvard Medical School helps us understand how the endolymphatic duct and sac stabilize the inner ear’s environment to identify ways to restore or elevate this function to mitigate or cure Meniere’s disease.
By Suzanne Wu
For the first time, neuroscientists have systematically identified the white matter “scaffold” of the human brain, the critical communications network that supports brain function.
Their work, published Feb. 11 in the open-source journal Frontiers in Human Neuroscience, has major implications for understanding brain injury and disease.
Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have shown, for the first time, that taking aspirin correlated with halted growth of acoustic neuromas, a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.
Intra-tympanic gentamicin is a widely used treatment for unilateral Meniere’s disease. Though the treatments are applied to only one ear, the adaptive effects in the untreated ear have not been widely studied.
Medical device manufacturer Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com) has contracted with Pittsburgh's Allegheny General Hospital (AGH) (www.wpahs.org/agh) to collaborate on the analysis of clinical trials underway at two military medical facilities, NKI said today.